300725 药石科技
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)4.5987.19012.35922.51513.980
总资产报酬率 ROA (%)2.6313.9617.50916.40410.665
投入资产回报率 ROIC (%)2.8454.3068.45218.7038.197

边际利润分析
销售毛利率 (%)39.72342.51945.47648.12545.788
营业利润率 (%)12.19410.70018.60641.02418.991
息税前利润/营业总收入 (%)16.78115.97920.15443.61721.991
净利润/营业总收入 (%)11.68511.44020.43641.92418.020

收益指标分析
经营活动净收益/利润总额(%)78.548107.50692.30252.19197.133
价值变动净收益/利润总额(%)27.127-4.5054.52347.2311.278
营业外收支净额/利润总额(%)7.07216.6128.2162.9175.075

偿债能力分析
流动比率 (X)3.3352.6683.5982.2873.936
速动比率 (X)2.2071.9822.6831.7193.285
资产负债率 (%)40.99944.50945.34125.07121.877
带息债务/全部投入资本 (%)34.44738.52038.41416.915--
股东权益/带息债务 (%)185.814155.374156.037478.035752.358
股东权益/负债合计 (%)143.909124.674120.552276.092357.111
利息保障倍数 (X)4.5865.077-171.42732.06811.076

营运能力分析
应收账款周转天数 (天)104.41483.86859.99055.1780.000
存货周转天数 (天)324.515254.331232.755218.7610.000